ATOSSA THERAPEUTICS, INC. — All Filings
620 total filings on record
Public companies registered with the SEC are required to file periodic reports, disclosures, and notices throughout the year. The most important are the 10-K (annual report), 10-Q (quarterly report), and 8-K (material event notice). Use the filters below to narrow by form type.
All
10-K
10-K/A
10-Q
10-Q/A
3
4
4/A
424B2
424B3
424B4
424B5
5
8-A12B
8-K
8-K/A
ARS
CERTNAS
CORRESP
CT ORDER
D
D/A
DEF 14A
DEFA14A
DEL AM
EFFECT
FWP
POS AM
PRE 14A
RW
S-1
S-1/A
S-3
S-3MEF
S-8
SC 13D
SC 13D/A
SC 13G
SC 13G/A
SCHEDULE 13G/A
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| 10-K | 10-K | 0001193125-26-124396 | Mar 25, 2026 | Dec 31, 2025 |
| 8-K | 8-K | 0001193125-26-124393 | Mar 25, 2026 | — |
| PRE 14A | PRE 14A | 0001193125-26-117826 | Mar 20, 2026 | — |
| 8-K | 8-K | 0001193125-26-061412 | Feb 20, 2026 | Feb 19, 2026 |
| 424B5 | 424B5 | 0001193125-26-061388 | Feb 20, 2026 | — |
| 424B3 | 424B3 | 0001193125-26-061342 | Feb 20, 2026 | — |
| 8-K | 8-K | 0001193125-26-054797 | Feb 17, 2026 | — |
| 8-K | 8-K | 0001193125-26-045628 | Feb 11, 2026 | — |
| 4/A | 4/A | 0001193125-26-030571 | Jan 30, 2026 | Jan 20, 2026 |
| 8-K | 8-K | 0001193125-26-021727 | Jan 26, 2026 | Jan 20, 2026 |
| 4 | 4 | 0001193125-26-019273 | Jan 22, 2026 | Jan 20, 2026 |
| 8-K | 8-K | 0001193125-26-008314 | Jan 9, 2026 | — |
| 8-K | 8-K | 0001193125-26-003506 | Jan 6, 2026 | — |
| DEF 14A | DEF 14A | 0001193125-25-327630 | Dec 22, 2025 | Dec 19, 2025 |
| PRE 14A | PRE 14A | 0001193125-25-317731 | Dec 12, 2025 | — |
| 8-K | 8-K | 0001193125-25-307516 | Dec 4, 2025 | — |
| 10-Q | 10-Q | 0001193125-25-276160 | Nov 12, 2025 | Sep 30, 2025 |
| 8-K | 8-K | 0001193125-25-276140 | Nov 12, 2025 | — |
| 4 | 4 | 0001193125-25-245114 | Oct 21, 2025 | Oct 14, 2025 |
| 3 | 3 | 0001193125-25-245087 | Oct 21, 2025 | Oct 14, 2025 |
| 8-K | 8-K | 0001193125-25-238065 | Oct 14, 2025 | — |
| 8-K | 8-K | 0001193125-25-220788 | Sep 26, 2025 | — |
| 8-K | 8-K | 0000950170-25-113371 | Sep 8, 2025 | — |
| 8-K | 8-K | 0000950170-25-110654 | Aug 21, 2025 | — |
| 10-Q | 10-Q | 0000950170-25-106947 | Aug 12, 2025 | Jun 30, 2025 |
| 8-K | 8-K | 0000950170-25-106944 | Aug 12, 2025 | — |
| SCHEDULE 13G/A | — | 0000932471-25-000827 | Jul 29, 2025 | — |
| SCHEDULE 13G/A | — | 0002052113-25-002482 | Jul 16, 2025 | — |
| 4 | 4 | 0000950170-25-076523 | May 22, 2025 | May 21, 2025 |
| 4 | 4 | 0000950170-25-073522 | May 16, 2025 | May 15, 2025 |
| 4 | 4 | 0000950170-25-073521 | May 16, 2025 | May 15, 2025 |
| 4 | 4 | 0000950170-25-073520 | May 16, 2025 | May 15, 2025 |
| 4 | 4 | 0000950170-25-073518 | May 16, 2025 | May 15, 2025 |
| 4 | 4 | 0000950170-25-073517 | May 16, 2025 | May 15, 2025 |
| 4 | 4 | 0000950170-25-073516 | May 16, 2025 | May 15, 2025 |
| 4 | 4 | 0000950170-25-073515 | May 16, 2025 | May 15, 2025 |
| 4 | 4 | 0000950170-25-073513 | May 16, 2025 | May 15, 2025 |
| 10-Q | 10-Q | 0000950170-25-069827 | May 13, 2025 | Mar 31, 2025 |
| 8-K | 8-K | 0000950170-25-069818 | May 13, 2025 | — |
| 8-K | 8-K | 0000950170-25-068333 | May 12, 2025 | May 8, 2025 |
| 8-K | 8-K | 0000950170-25-051575 | Apr 7, 2025 | — |
| 4 | 4 | 0000950170-25-046742 | Mar 28, 2025 | Mar 26, 2025 |
| ARS | ARS | 0000950170-25-045327 | Mar 26, 2025 | Dec 31, 2024 |
| DEF 14A | DEF 14A | 0000950170-25-045297 | Mar 26, 2025 | — |
| S-8 | S-8 | 0000950170-25-045202 | Mar 26, 2025 | — |
| 10-K | 10-K | 0000950170-25-044099 | Mar 25, 2025 | Dec 31, 2024 |
| 8-K | 8-K | 0000950170-25-044098 | Mar 25, 2025 | — |
| 8-K | 8-K | 0000950170-25-037634 | Mar 12, 2025 | Mar 11, 2025 |
| 8-K | 8-K | 0000950170-25-025596 | Feb 24, 2025 | Feb 21, 2025 |
| SCHEDULE 13G/A | — | 0001649553-25-000035 | Feb 7, 2025 | — |